title: Denosumab (prolia) for treatment of postmenopausal osteoporosis.
authors.affiliation: Shenandoah University Bernard J. Dunn School of Pharmacy, Winchester, VA, USA.
authors.forename: Gretchen L
authors.initials: GL
authors.lastname: Johnson
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000069448:Denosumab; D016527:Drug Costs; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000517:prevention & control; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D000069448:Denosumab